Summary
The herpesvirus human cytomegalovirus (HCMV), the largest known human virus, is a ubiquitous pathogen that persistently infects the majority of the world's population through the establishment of latency. Although asymptomatic in most healthy individuals, HCMV can lead to a severe congenital disease, as well as morbidity and mortality in immunocompromised adults. Despite the prevalence and pathogenicity of HCMV, many fundamental questions about this pathogen remain open. We still do not know the complete list of functional elements in HCMV's complex genome and how these contribute to infection progression and latency, we do not understand the determinants that govern infection outcome, and we are missing tools that will facilitate systematic dissection of the host and viral factors that are needed for HCMV infection in different cell types.
In this proposal, we suggest to employ our expertise and to develop unique toolsets to shed light on the host and viral factors that regulate the HCMV life cycle. We propose to combine state-of-the art high-throughput tools with mechanistic studies to comprehensively characterize the viral elements that regulate HCMV progression (aim 1), decipher the determinants that dictate infection outcome (lytic vs. latent, aim 2) and develop and implement a sensitive screening platform that will facilitate easy dissection and characterization of HCMV essential components in any cell type (aim 3).
The knowledge generated from these objectives will provide a clearer depiction of the different determinants that control HCMV infection and will generate new tools for the benefit of the community. These in turn could help to expand our therapeutic options. More broadly, with its comprehensive and complementary approaches, this work will provide a paradigm for the study of other herpesviruses and for understanding complex host-pathogen interactions.
In this proposal, we suggest to employ our expertise and to develop unique toolsets to shed light on the host and viral factors that regulate the HCMV life cycle. We propose to combine state-of-the art high-throughput tools with mechanistic studies to comprehensively characterize the viral elements that regulate HCMV progression (aim 1), decipher the determinants that dictate infection outcome (lytic vs. latent, aim 2) and develop and implement a sensitive screening platform that will facilitate easy dissection and characterization of HCMV essential components in any cell type (aim 3).
The knowledge generated from these objectives will provide a clearer depiction of the different determinants that control HCMV infection and will generate new tools for the benefit of the community. These in turn could help to expand our therapeutic options. More broadly, with its comprehensive and complementary approaches, this work will provide a paradigm for the study of other herpesviruses and for understanding complex host-pathogen interactions.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/864012 |
| Start date: | 01-06-2020 |
| End date: | 31-05-2025 |
| Total budget - Public funding: | 2 000 000,00 Euro - 2 000 000,00 Euro |
Cordis data
Original description
The herpesvirus human cytomegalovirus (HCMV), the largest known human virus, is a ubiquitous pathogen that persistently infects the majority of the world's population through the establishment of latency. Although asymptomatic in most healthy individuals, HCMV can lead to a severe congenital disease, as well as morbidity and mortality in immunocompromised adults. Despite the prevalence and pathogenicity of HCMV, many fundamental questions about this pathogen remain open. We still do not know the complete list of functional elements in HCMV's complex genome and how these contribute to infection progression and latency, we do not understand the determinants that govern infection outcome, and we are missing tools that will facilitate systematic dissection of the host and viral factors that are needed for HCMV infection in different cell types.In this proposal, we suggest to employ our expertise and to develop unique toolsets to shed light on the host and viral factors that regulate the HCMV life cycle. We propose to combine state-of-the art high-throughput tools with mechanistic studies to comprehensively characterize the viral elements that regulate HCMV progression (aim 1), decipher the determinants that dictate infection outcome (lytic vs. latent, aim 2) and develop and implement a sensitive screening platform that will facilitate easy dissection and characterization of HCMV essential components in any cell type (aim 3).
The knowledge generated from these objectives will provide a clearer depiction of the different determinants that control HCMV infection and will generate new tools for the benefit of the community. These in turn could help to expand our therapeutic options. More broadly, with its comprehensive and complementary approaches, this work will provide a paradigm for the study of other herpesviruses and for understanding complex host-pathogen interactions.
Status
SIGNEDCall topic
ERC-2019-COGUpdate Date
27-04-2024
Images
No images available.
Geographical location(s)
